Ivermectin vs Remdesivir for COVID-19

On August 26, 2021, the CDC recently put out a Health Advisory – Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19.

In it, the CDC reports adverse reactions from people taking ivermectin that physicians did not prescribe. Here’s a quote,

Ivermectin is not authorized or approved by FDA for prevention or treatment of COVID-19. The National Institutes of Health’s (NIH) COVID-19 Treatment Guidelines Panel has also determined that there are currently insufficient data to recommend ivermectin for treatment of COVID-19.

Clinical trials and observational studies to evaluate the use of ivermectin to prevent and treat COVID-19 in humans have yielded insufficient evidence for the NIH COVID-19 Treatment Guidelines Panel to recommend its use.

Data from adequately sized, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin in the treatment of COVID-19.

So they claim that there is not enough data to approve ivermectin. So what is being used? Currently, the recommendation of the National Institue of Health for the Therapeutic Management of Hospitalized Adults With COVID-19 among patients who require oxygen is remdesivir

Source: NIH

The meaning of BIIa is described below.

BIIa means that the recommendation is “Moderate” based on “Other randomized trials or subgroup analyses of randomized trials”.

How many trials does remdesivir have?

We look at screenshots from c19rmd.comc19rmd.com puts together all the remdesivir studies related to COVID-19.

Source: c19rmd.com

The meta-analysis table above shows the studies listed on the left. The Improvement or Relative Risk (RR) is only 22%. On the right side, the horizontal lines with the green squares and diamonds reflect the studies with positive results, while the red squares are negative. The size of the square reflects the number of people studied.

The bottom line on the above meta-analysis among 21 remdesivir studies is a 22% improvement of COVID-19 patients.

Now let’s compare ivermectin studies from c19ivermectin.com.

ivmmeta.com

Ivermectin has 27 COVID-19 early treatment studies, and the improvement is 69%

Remdesivir, 21 studies with 22% improvement. Ivermectin, 27 studies with 69% improvement. It’s quite clear ivermectin is better for early treatment.

How about deaths?

Again from c19rmd.com.

c19rmd.com

20 studies about remdesivir COVID-19 mortality results in 22% improvement for late treatment.

Here is a scary one.

c19rmd.com

All studies -36% improvement.

How about the mortality results for ivermectin?

From ivmmeta.com

ivmmeta.com

All 25 ivermectin COVID-19 mortality results:

  • Early treatment 37% improvement
  • Late treatment  53% improvement
  • Prophylaxis       96% improvement
  • All 25 studies    58% improvement

Compared with 20 studies about remdesivir COVID-19 mortality results with only  22% improvement for late treatment.

Ivermectin is better. Why do the NIH, CDC, and FDA ignore the ivermectin studies? Could it be so that the COVID-19 vaccines will be given Emergency Use Authorization?

According to the FDA, one criterion for the Emergency Use Authorization for
Vaccines to Prevent COVID-19 one page 3, (emphasis mine)

There is no adequate, approved, and available alternative to the product for diagnosing, preventing, or treating the disease or condition.

Note that remdesivir is also being used under FDA Emergency Use Authorization. (EUA)

Are the CDC, NIH, and the FDA ignoring the ivermectin studies to grant EUA to the COVID-19 vaccines? Is it possible?

If the FDA, CDC, and NIH approve ivermectin, there can be a 96% improvement if given for prevention, 37% improvement for early treatment, and 53% improvement for the late treatment of COVID-19. This COVID-19 pandemic will not be used for scaremongering!

The FDA, CDC, and the NIH are to blame for people using ivermectin for animals

If the NIH, CDC, and FDA look at the studies for ivermectin and approve it, there won’t be any need for people to buy and use ivermectin for animals. Prescriptions would be easily available from doctors.

The blame for all of these reports about people having adverse reactions after taking ivermectin for animal use is the CDC, FDA, and NIH. They should look at the study that clearly shows that ivermectin is life-saving against COVID-19.

Knowledge about Covid-19 is rapidly evolving. Information may update as new studies are made. Stay current by subscribing. Feel free to share and like.

Don’t Get Sick!

Related:

  1. Solved! The Ivermectin African Enigma
  2. IVMMETA.COM: A website of studies on Ivermectin’s efficacy
  3. What makes Ivermectin a kick-ass antiviral?
  4. News that ivermectin overdose is clogging up hospitals is not true

As an Amazon Associate, I earn from qualifying purchases.